Literature DB >> 18283797

Systemic mastocytosis.

Peter Valent1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18283797     DOI： 10.1007/978-0-387-73744-7_18

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  8 in total

Review 1.  Systemic mastocytosis: a gastroenterological perspective.

Authors:  Hamish Philpott; Paul Gow; Peter Crowley; Sanjay Nandurkar; Jo Douglass; Peter R Gibson
Journal:  Frontline Gastroenterol       Date:  2011-09-10

Review 2.  Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.

Authors:  Siham Bibi; Melis Dilara Arslanhan; Florent Langenfeld; Sylvie Jeanningros; Sabine Cerny-Reiterer; Emir Hadzijusufovic; Luba Tchertanov; Richard Moriggl; Peter Valent; Michel Arock
Journal:  Haematologica       Date:  2014-03       Impact factor: 9.941

3.  Systemic mastocytosis presenting as acute appendicitis: a case report and review of the literature.

Authors:  Syed A Akbar; Shahzad Raza; Jason E Denney; Eric J Johannesen; Donald C Doll
Journal:  Case Rep Oncol       Date:  2013-03-29

4.  Irritable bowel syndrome - An inflammatory disease involving mast cells.

Authors:  Hamish Philpott; Peter Gibson; Frank Thien
Journal:  Asia Pac Allergy       Date:  2011-04-26

Review 5.  Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder.

Authors:  Anindya Chatterjee; Joydeep Ghosh; Reuben Kapur
Journal:  Oncotarget       Date:  2015-07-30

6.  Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice.

Authors:  Namit Sharma; Stephanie Everingham; Li-Fan Zeng; Zhong-Yin Zhang; Reuben Kapur; Andrew W B Craig
Journal:  Oncotarget       Date:  2014-08-15

7.  A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.

Authors:  Siham Bibi; Yanyan Zhang; Caroline Hugonin; Mallorie Depond Mangean; Liang He; Ghaith Wedeh; Jean-Marie Launay; Sjoerd Van Rijn; Thomas Würdinger; Fawzia Louache; Michel Arock
Journal:  Oncotarget       Date:  2016-12-13

8.  Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation.

Authors:  Emir Hadzijusufovic; Barbara Peter; Laura Rebuzzi; Christian Baumgartner; Karoline V Gleixner; Alexander Gruze; Tuddow Thaiwong; Winfried F Pickl; Vilma Yuzbasiyan-Gurkan; Michael Willmann; Peter Valent
Journal:  Vet Immunol Immunopathol       Date:  2009-05-18       Impact factor: 2.046
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.